95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Negative revenue growth while PAAS stands at 2.26%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.50%
Negative net income growth while PAAS stands at 9.30%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while PAAS is at 4.76%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while PAAS is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.61%
Share reduction more than 1.5x PAAS's 6.79%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.64%
Diluted share reduction more than 1.5x PAAS's 6.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.76%
Negative FCF growth while PAAS is at 70.86%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
156.85%
10Y revenue/share CAGR at 75-90% of PAAS's 180.38%. Bill Ackman would press for new markets or product lines to narrow the gap.
-43.56%
Negative 5Y CAGR while PAAS stands at 129.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
3Y revenue/share CAGR under 50% of PAAS's 271.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
5Y OCF/share CAGR above 1.5x PAAS's 578.63%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
785.71%
3Y OCF/share CAGR under 50% of PAAS's 2261.21%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
5Y net income/share CAGR above 1.5x PAAS's 1048.93%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
658.94%
Below 50% of PAAS's 2985.97%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
698.75%
10Y equity/share CAGR above 1.5x PAAS's 178.69%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
729.85%
5Y equity/share CAGR above 1.5x PAAS's 275.10%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1036.77%
3Y equity/share CAGR above 1.5x PAAS's 80.09%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Firm’s AR is declining while PAAS shows 19.07%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Asset growth 1.25-1.5x PAAS's 3.05%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
2.31%
Positive BV/share change while PAAS is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while PAAS invests at 13.37%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.